New Yorker goes inside Chinese genomics giant BGI; Tute Genomics raises $1.5M for genome analysis;

> The New Yorker has taken a detailed look at Chinese genomics giant BGI. Article (sub. req.)

> Tute Genomics has raised $1.5M to develop its cloud-based genome analysis software. Release

> Pharma service provider Lonza has renewed its communication infrastructure deal with Orange Business Services. Release

> Forbes' Matthew Herper has looked at whether Big Data could replace some clinical trials. Feature

> Curie-Cancer has created a medical image analysis and management platform. Item

> ePharmaSolutions has begun pilot projects of its algorithm-driven tool to match patients to trials. News

> PMLiVE has argued that pharma's use of mobile moved up a gear in 2013. Commentary

> Clinovo will introduce updates to its open source data capture tool later this month. Release

Suggested Articles

There's no evidence personal patient information leaked during the 11-week breach, but the same can't be said about Sangamo's own secrets.

Through a new online tracker, AllTrials names sponsors who fail to report clinical trial results on time per the FDAAA Final Rule.

The new solution aims to streamline the incorporation of human genomic data into clinical trial designs.